Literature DB >> 6204887

Antibodies against a retinal guanine nucleotide-binding protein cross-react with a single plasma membrane protein in non-retinal tissues.

P Gierschik, C Simons, C Woodard, R Somers, A Spiegel.   

Abstract

Antisera (AS/1-AS/6) to purified bovine retinal transducin, a guanine nucleotide-binding protein, were produced in 6 rabbits. Immunoblots showed that the antisera varied in their reactivity with the subunits of transducin; AS/1 reacted strongly with all 3 subunits, while the others reacted with only the beta and/or gamma subunits. Only AS/1 specifically immunoprecipitated the alpha subunit radiolabeled with non-covalently bound guanine nucleotides. Immunostaining of plasma membrane proteins from non-retinal tissues with AS-1 revealed a single protein (approx. 35 kDa), most likely representing the beta subunit of the guanine nucleotide-binding proteins (Gs and Gi) associated with adenylate cyclase. Cerebral cortex showed the highest content of this protein. Antisera against transducin provide a highly specific and sensitive probe for quantitation of the beta subunit of Gs and Gi.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204887     DOI: 10.1016/0014-5793(84)81149-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Specific enhancement of beta-adrenergic receptor kinase activity by defined G-protein beta and gamma subunits.

Authors:  S Müller; M Hekman; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  A C-terminal peptide of bovine rhodopsin binds to the transducin alpha-subunit and facilitates its activation.

Authors:  W J Phillips; R A Cerione
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

3.  The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity.

Authors:  J A Pitcher; E S Payne; C Csortos; A A DePaoli-Roach; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.